10-year CVD incidence | ||||||
Age | ||||||
≤45 years (n = 1080) | > 45 years (n = 940) | |||||
RR | 95%CI | P value | RR | 95%CI | P value | |
TC, mg/dL | 1.013 | 1.001, 1.026 | 0.030 | 1.001 | 0.997, 1.005 | 0.795 |
LDL-C, mg/dL | 1.013 | 1.000, 1.027 | 0.049 | 0.999 | 0.994, 1.003 | 0.516 |
HDL-C, mg/dL | 0.999 | 0.981, 1.027 | 0.543 | 0.990 | 0.977, 1.000 | 0.050 |
TG, mg/dL | 1.001 | 0.997, 1.005 | 0.692 | 1.001 | 1.000, 1.002 | 0.041 |
Lp(a), mg/dL | 1.003 | 0.991, 1.016 | 0.611 | 1.005 | 1.000, 1.009 | 0.048 |
Sex | ||||||
Males (n = 1006) | Females (n = 1014) | |||||
RR | 95%CI | P value | RR | 95%CI | P value | |
TC, mg/dL | 1.002 | 0.998, 1.007 | 0.269 | 1.004 | 0.997, 1.011 | 0.301 |
LDL-C, mg/dL | 1.001 | 0.996, 1.005 | 0.731 | 1.004 | 0.995, 1.013 | 0.354 |
HDL-C, mg/dL | 0.992 | 0.976, 1.009 | 0.347 | 0.996 | 0.978, 1.014 | 0.663 |
TG, mg/dL | 1.001 | 1.000, 1.002 | 0.050 | 1.000 | 0.997, 1.004 | 0.937 |
Lp(a), mg/dL | 1.000 | 0.994, 1.006 | > 0.999 | 1.007 | 1.001, 1.013 | 0.024 |
Body weight status | ||||||
Normal-weight (n = 845) | Overweight/obese (n = 1175) | |||||
RR | 95%CI | P value | RR | 95%CI | P value | |
TC, mg/dL | 1.009 | 1.000, 1.018 | 0.050 | 1.002 | 0.998, 1.006 | 0.410 |
LDL-C, mg/dL | 1.011 | 1.000, 1.022 | 0.048 | 1.000 | 0.996, 1.005 | 0.864 |
HDL-C, mg/dL | 0.992 | 0.968, 1.017 | 0.518 | 0.994 | 0.980, 1.007 | 0.370 |
TG, mg/dL | 1.002 | 0.998, 1.005 | 0.307 | 1.001 | 1.000, 1.002 | 0.010 |
Lp(a), mg/dL | 1.006 | 0.998, 1.015 | 0.153 | 1.001 | 0.997, 1.006 | 0.653 |
Adherence to the Mediterranean diet | ||||||
High (n = 1000) | Low (n = 1020) | |||||
RR | 95%CI | P value | RR | 95%CI | P value | |
TC, mg/dL | 1.003 | 0.992, 1.014 | 0.599 | 1.002 | 0.998, 1.006 | 0.304 |
LDL-C, mg/dL | 0.995 | 0.982, 1.009 | 0.511 | 1.001 | 0.997, 1.005 | 0.658 |
HDL-C, mg/dL | 0.999 | 0.963, 1.035 | 0.943 | 0.992 | 0.979, 0.999 | 0.049 |
TG, mg/dL | 1.008 | 0.997, 1.019 | 0.143 | 1.001 | 1.000, 1.002 | 0.050 |
Lp(a), mg/dL | 1.008 | 0.996, 1.021 | 0.192 | 1.002 | 0.997, 1.007 | 0.360 |
Use of lipid-lowering medication | ||||||
Yes (n = 106) | No (n = 1914) | |||||
RR | 95%CI | P value | RR | 95%CI | P value | |
TC, mg/dL | 1.000 | 0.992, 1.006 | 0.761 | 1.005 | 1.000, 1.009 | 0.031 |
LDL-C, mg/dL | 0.996 | 0.987, 1.004 | 0.314 | 1.004 | 1.000, 1.009 | 0.050 |
HDL-C, mg/dL | 0.995 | 0.959, 1.032 | 0.780 | 0.992 | 0.979, 1.005 | 0.235 |
TG, mg/dL | 1.003 | 1.001, 1.006 | 0.016 | 1.000 | 0.999, 1.002 | 0.461 |
Lp(a), mg/dL | 1.002 | 0.983, 1.063 | 0.805 | 1.003 | 0.998, 1.008 | 0.194 |
Presence of hypercholesterolemia | ||||||
Yes (n = 839) | No (n = 1181) | |||||
RR | 95%CI | P value | RR | 95%CI | P value | |
TC, mg/dL | 1.002 | 0.997, 1.065 | 0.399 | 1.003 | 0.993, 1.012 | 0.605 |
LDL-C, mg/dL | 1.001 | 0.996, 1.006 | 0.768 | 1.001 | 0.991, 1.011 | 0.845 |
HDL-C, mg/dL | 0.980 | 0.964, 0.996 | 0.015 | 1.007 | 0.990, 1.025 | 0.424 |
TG, mg/dL | 1.001 | 1.000, 1.002 | 0.050 | 1.000 | 0.998, 1.002 | 0.786 |
Lp(a), mg/dL | 1.003 | 0.997, 1008 | 0.385 | 1.003 | 0.995, 1.011 | 0.456 |